據(ju)統(tong)計(ji)，今日晚間已有10家(jia)(jia)(jia)科創(chuang)(chuang)板(ban)公(gong)(gong)(gong)(gong)司提交回(hui)(hui)購(gou)(gou)相(xiang)關公(gong)(gong)(gong)(gong)告(gao)(gao)。其中，聯影醫(yi)療、成(cheng)大(da)生物(wu)、中觸媒、杰普特4家(jia)(jia)(jia)公(gong)(gong)(gong)(gong)司新增回(hui)(hui)購(gou)(gou)方(fang)案(an)，聯影醫(yi)療回(hui)(hui)購(gou)(gou)上下限分(fen)別(bie)為8億(yi)(yi)元(yuan)和4億(yi)(yi)元(yuan)，為8月(yue)以來科創(chuang)(chuang)板(ban)回(hui)(hui)購(gou)(gou)金(jin)(jin)額(e)(e)最高的公(gong)(gong)(gong)(gong)司。此外，大(da)全能(neng)源、麥瀾德(de)、嘉(jia)和美康等6家(jia)(jia)(jia)公(gong)(gong)(gong)(gong)司發布(bu)回(hui)(hui)購(gou)(gou)相(xiang)關的進展公(gong)(gong)(gong)(gong)告(gao)(gao)。據(ju)統(tong)計(ji)，8月(yue)以來，累計(ji)56家(jia)(jia)(jia)科創(chuang)(chuang)板(ban)公(gong)(gong)(gong)(gong)司提議回(hui)(hui)購(gou)(gou)或發布(bu)回(hui)(hui)購(gou)(gou)方(fang)案(an)，累計(ji)回(hui)(hui)購(gou)(gou)金(jin)(jin)額(e)(e)上限達(da)到56.08億(yi)(yi)元(yuan)。回(hui)(hui)購(gou)(gou)上限金(jin)(jin)額(e)(e)在1億(yi)(yi)元(yuan)以上的有8家(jia)(jia)(jia)，不乏聯影醫(yi)療、晶科能(neng)源、納芯微、大(da)全能(neng)源等多家(jia)(jia)(jia)科創(chuang)(chuang)50指(zhi)數成(cheng)份股。（證券時報）